Evidence map›Paper›PMID 39447595›Full record

ArticleEndocrinology, diabetes & metabolism case reports2024

MCM9 compound heterozygosity in an adolescent with premature ovarian insufficiency.

Elise Nauwynck, Michel De Vos, Alexander Gheldof, Bart Jh Dequeker, Annelore Van Der Kelen, Frederik Hes, Stephanie Verheyden, Jesse Vanbesien, Inge Gies, Jean De Schepper and 1 more

Abstract read
In one paragraph

Article in Endocrinology, diabetes & metabolism case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Structural Activation of DNA Unwinding by MCM8/9/HROB.bioRxiv : the preprint server for biology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Elise NauwynckDivision of Pediatric Endocrinology, KidZ Health Castle, UZ Brussel, Vrije Universiteit Brussel, Brussels, Belgium.ORCID 0000-0001-9136-9126
Michel De VosBrussels IVF, Vrije Universiteit Brussel, Brussels, Belgium.ORCID 0000-0001-5019-5924
Alexander GheldofDivision of Genetics, UZ Brussel, Vrije Universiteit Brussel, Brussels, Belgium.ORCID 0000-0002-8320-1961
Bart Jh DequekerDivision of Genetics, UZ Brussel, Vrije Universiteit Brussel, Brussels, Belgium.
Annelore Van Der KelenDivision of Genetics, UZ Brussel, Vrije Universiteit Brussel, Brussels, Belgium.ORCID 0000-0002-9065-1960
Frederik HesClinical Sciences, Research Group Reproduction and Genetics, Centre for Medical Genetics, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.ORCID 0000-0002-3025-0882
Stephanie VerheydenPediatrics, OLV Aalst Campus Asse, Asse, Belgium.
Jesse VanbesienDivision of Pediatric Endocrinology, KidZ Health Castle, UZ Brussel, Vrije Universiteit Brussel, Brussels, Belgium.ORCID 0000-0001-8817-6139
Inge GiesDivision of Pediatric Endocrinology, KidZ Health Castle, UZ Brussel, Vrije Universiteit Brussel, Brussels, Belgium.ORCID 0000-0002-8571-0858
Jean De SchepperDivision of Pediatric Endocrinology, KidZ Health Castle, UZ Brussel, Vrije Universiteit Brussel, Brussels, Belgium.ORCID 0000-0002-2999-0250
Willem StaelsDivision of Pediatric Endocrinology, KidZ Health Castle, UZ Brussel, Vrije Universiteit Brussel, Brussels, Belgium.ORCID 0000-0001-8259-3329

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Summary: Delayed puberty in girls is often related to late maturation but is occasionally the first sign of premature ovarian insufficiency (POI). POI is a condition that affects ovarian function and fertility, and its etiology is unknown in most cases. Genetic factors have recently been identified in 20-25% of women with POI, involving genes that regulate various aspects of ovarian development and maintenance. We report a case of delayed puberty due to POI in an adolescent from a non-consanguineous family who carried two variants in the MCM9 gene. MCM9 is essential for DNA replication and repair, and its dysfunction can lead to chromosomal instability and ovarian failure. Our case highlights the importance of targeted gene panel analysis, particularly in POI patients with negative autoimmunity screening, and evidence of ovarian or uterine dysgenesis on pelvic imaging. Learning points: Delayed puberty in girls is often self-limiting, but it can also indicate underlying conditions with lifelong implications, such as premature ovarian insufficiency (POI). Patients with POI, negative autoimmune screening, a normal karyotype, and no FMR premutation should undergo further genetic testing, preferably through targeted gene panels. Compound heterozygous variants in MCM9 can cause POI, presenting with delayed puberty and primary amenorrhea in girls without a consanguineous family.

Indexed as

case reportdelayed pubertyMCM9monogenicpremature ovarian insufficiency

Identifiers

PMID39447595
PMCPMC11558971

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.